Dr. Tolga Atilla Ceranoglu, MD

Dr. Ceranoglu practices at Shriners Children's Boston in Boston, Massachusetts, part of Shriners Hospitals for Children.

Dr. Ceranoglu's NPI, 1174591465, was assigned on March 10, 2006. Dr. Ceranoglu graduated from Marmara Univ- Fac Med in 1998. Dr. Ceranoglu's Massachusetts license number on file is 215949.

Dr. Ceranoglu's primary practice is Shriners Children's Boston, at 51 Blossom Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 722-3000.

Dr. Ceranoglu's primary practice is Shriners Children's Boston in Boston, Massachusetts, part of Shriners Hospitals for Children. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Ceranoglu to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ceranoglu practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Ceranoglu's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Ceranoglu is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Dr. Ceranoglu has a license on file in Massachusetts.

Dmand AI lists intellectual and developmental disabilities among the conditions Dr. Ceranoglu treats.

CMS data shows 40 Medicare services from Dr. Ceranoglu across 1 procedure code in 2024, all of them office visits, for 15 Medicare patients. Medicare paid $3,097 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Dr. Ceranoglu in 2024. 75% of them have anxiety. Their average risk score is 0.63, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ceranoglu's median patient age at 16, with 31% women.

In 2024, Dr. Ceranoglu wrote 366 Medicare Part D claims for 32 patients. 92% of them were for generic drugs. CMS names the drug for 268 of them, across 16 drugs with 11 or more claims each, at $29,260 in total drug cost. In 2023, CMS named 297 claims across 16 drugs.

Dr. Ceranoglu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ceranoglu as offering telehealth.

Dmand AI links 13 papers to Dr. Ceranoglu, published from 2018 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Autism Spectrum Disorder, Burns and Attention Deficit Disorder with Hyperactivity. Dr. Ceranoglu has published most often in J Burn Care Res. Dr. Ceranoglu's most frequent co-authors are Gagan Joshi, MD, Abigail Hinchliffe Belser, MD and Philip Hyungjin Chang, MD.

Dmand AI links Dr. Ceranoglu to 1 clinical trial. Conditions studied include Autistic Disorder and Autism Spectrum Disorder.

Dr. Ceranoglu serves on AACAP Media Committee.

Dr. Ceranoglu graduated from Marmara Univ- Fac Med in 1998.

Dr. Ceranoglu is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.